Grith Lykke Sørensen

Civil status

Born July 27, 1971. Danish citizenship. Married. Two children born 2004 and 2007.

Education and academic qualifications

2017 DMSc from University of Southern Denmark (SDU) (29/9-2017)

2003 Ph.D. from SDU (5/12-2003)

2000 Stay at Sct. Radcliffe Hospital in Oxford in Dr. Zsuzsa Kertesz laboratory

2000 Change of Ph.D-project, now at Immunology and Microbiology, SDU

1998 Ph.d.-position at SDU, The Faculty of Science and Engineering

1998 M.Sc. from University of Copenhagen in human biology

Employment

2018 Professor MSO position Cancer and Inflammation Research, Institute of Molecular Medicine (IMM), SDU

2016 Sick leave (2/11-2016 – 6/6-2017)

2014 Associate Professor position at Cancer and Inflammation research, IMM, SDU

2009 Associate Professor position at Cardiovascular and Renal Research, IMM, SDU

2007 Assistant Professor position at Medical Biotechnology Center (MBC), SDU

2007 Maternal leave (7/3-2007 – 19/10-2007)

2003 Maternal leave (19/12-2003 – 2/7-2004)

2003 Research assistant at Institute of Medical Biology (IMB), SDU

Other scientific qualifications

Chairman of 6 PhD-defenses, member of assessment committee of 5 Ph.D.-defenses in DK

and UK

2021 Consultant for Biotech Airway Therapeutics developing surfactant protein D (AT-100) for therapeutic clinical use.

2021 Member of Grant review panel – Academy of Finland

2018 Member of Grant review panel for South-Eastern Norway regional health authority’s (Helse Sør-Øst RHF) funding of research projects

2015 Member of editorial board of Frontiers in Immunology; Molecular Innate Immunity.

Innovation: Co-inventor of five patents, and cofounder of Biolectin in 2000. Main driver of a study of anti-MFAP4 antibodies as a new drug for treatment of age-related macular degeneration (AMD) and diabetic macular edema.

Academic awards

2018 Innovationsprisen, SDU

2006 Lundbeckfonden award; GL-Sorensen salary

2006 Danish Council for Independent Research award; GL-Sorensen salary

Management experience

2018 -> today Project leader for the DARE project under investment from Innovation Fund Denmark

2018 - 2019 INSEAD Research leader course, Copenhagen/Paris Fontaine Bleu

2011 Research Leader and Management Course at the Copenhagen Business School

2010-2018 Project leader for Center for COPD research CeKOL (www.cekol.dk) funded by the Danish Strategic Research Council

Recent funding:

Augustinusfonden [2021-2023]: 148.00 €

The Danish Innovation Foundation [2017-2021]: 2.278.000€; SDU co-financing: 406.000 €

Novo Nordisk endocrinology and metabolism grant [2019-2021]: 267.000 €

BII PoC [2020-2021]: 126.000 €

Novo Nordisk Bioscience and Basic Biomedicine 2017/2018: 160.000 €

Novo Nordisk endocrinology and metabolism grant 2017: 180.000 €

The Danish Research Council grant 2017: 350.000 €

Novo Nordisk endocrinology research

Novo Nordisk Pre-Seed grant (Collaboration; total of 357.000 €) 2015: 143.000 €

The Lundbeck Foundation 2014: 214.000 €

Supervision

Main supervisor of 2 previous post docs, 8 graduated and 4 current Ph.D.-students.

Co-supervisor of 14 previous Ph.D.-students.